Atlas Trials

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Clinical trial NCT03988855 · UNKNOWN

Trial details

NCT number
NCT03988855
Sponsor
Deinove
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Clostridium Difficile (C. Difficile)
Start date
2019-08-02
Primary completion
2022-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.